Metastatic renal cell carcinoma in a child: 11-year disease-free survival following surgery.

A child with metastatic renal cell carcinoma (RCC) is presented. This case is unusual in that the patient has remained disease free for 11 years following surgery and only one course of chemotherapy prior to thoracotomy. The management of metastatic RCC is reviewed and the genetic mechanisms leading to its development briefly discussed.

[1]  M. Hernández-Martí,et al.  Renal adenocarcinoma in an 8-year-old child, with a t(X;17)(p11.2;q25). , 1995, Cancer genetics and cytogenetics.

[2]  V. Tonk,et al.  Renal cell carcinoma with translocation (X;1). Further evidence for a cytogenetically defined subtype. , 1995, Cancer genetics and cytogenetics.

[3]  L. Robison,et al.  Incidence of cancer in children in the United States. Sex‐, race‐, and 1‐year age‐specific rates by histologic type , 1995, Cancer.

[4]  H. Kempski,et al.  A case of acute megakaryoblastic leukaemia with t(X;6)(p11.21;q23) having an X chromosome breakpoint within a 450-Kb region which is also disrupted in two classes of solid tumours. , 1995, Leukemia.

[5]  B. Seizinger,et al.  Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. , 1994, American journal of human genetics.

[6]  C. Cooper,et al.  Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma , 1994, Nature Genetics.

[7]  Y Kubota,et al.  Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. , 1994, Cancer research.

[8]  J. Brooks,et al.  Mutations of the VHL tumour suppressor gene in renal carcinoma , 1994, Nature Genetics.

[9]  R. Cerfolio,et al.  Pulmonary resection of metastatic renal cell carcinoma. , 1994, The Annals of thoracic surgery.

[10]  C. Timmons,et al.  Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint. , 1991, Cancer genetics and cytogenetics.

[11]  H. Kirchner,et al.  Home therapy with recombinant interleukin-2 and interferon-α2b in advanced human malignancies , 1990, The Lancet.

[12]  Todd Mb,et al.  Therapeutic options in renal cell carcinoma. , 1989 .

[13]  S. Sallan,et al.  Renal cell carcinoma in childhood and adolescence: a clinical and pathological study of 17 cases. , 1985, The Journal of urology.

[14]  N. Palmer,et al.  Renal cell carcinoma in children. , 1983, Medical and pediatric oncology.

[15]  D. Harris.  Hormonal therapy and chemotherapy of renal-cell carcinoma. , 1983, Seminars in oncology.

[16]  S. Fuhrman,et al.  Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.

[17]  B. Aron,et al.  Renal adenocarcinoma in children: incidence, therapy and prognosis. , 1974, The Journal of urology.

[18]  H. Bloom.  Hormone‐induced and spontaneous regression of metastatic renal cancer , 1973 .

[19]  L. Dehner,et al.  Renal cell carcinoma in children: a clinicopathologic study of 15 cases and review of the literature. , 1970, The Journal of pediatrics.

[20]  R. Kodet,et al.  Renal cell carcinoma in children: a single institution's experience. , 1994, Medical and pediatric oncology.

[21]  J. Miller,et al.  Pediatric renal cell carcinoma: a complete response to recombinant interleukin-2 in a child with metastatic disease at diagnosis. , 1994, Medical and pediatric oncology.

[22]  N. Breslow,et al.  Position paper: imaging methods for primary renal tumors of childhood: costs versus benefits. , 1993, Medical and pediatric oncology.

[23]  J. Mark,et al.  Chromosomal patterns in human benign uterine leiomyomas. , 1990, Cancer genetics and cytogenetics.

[24]  H. Mensink,et al.  Cytogenetics of 12 cases of renal adenocarcinoma. , 1988, Cancer genetics and cytogenetics.

[25]  Rosenberg Sa.  Immunotherapy of patients with advanced cancer using interleukin-2 alone or in combination with lymphokine activated killer cells. , 1988 .

[26]  T. Berge,et al.  Unrecognized renal cell carcinoma. Clinical and pathological aspects. , 1981, Scandinavian journal of urology and nephrology.